Cibc Private Wealth Group, LLC Tg Therapeutics, Inc. Transaction History
Cibc Private Wealth Group, LLC
- $52.7 Billion
- Q4 2024
A detailed history of Cibc Private Wealth Group, LLC transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 1,189 shares of TGTX stock, worth $36,716. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,189
Previous 1,439
17.37%
Holding current value
$36,716
Previous $33,000
6.06%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding TGTX
# of Institutions
371Shares Held
85.5MCall Options Held
3.78MPut Options Held
3M-
Vanguard Group Inc Valley Forge, PA15.6MShares$482 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$352 Million0.0% of portfolio
-
State Street Corp Boston, MA9.2MShares$284 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA3.19MShares$98.6 Million0.01% of portfolio
-
Pictet Asset Management Holding Sa Carouge, V82.79MShares$86.3 Million0.09% of portfolio
About TG THERAPEUTICS, INC.
- Ticker TGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 145,274,000
- Market Cap $4.49B
- Description
- TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...